Reclipsen
Ingredients: Desogestrel 0.15 mg and ethinyl estradiol 0.03 mg
Pack: 28 tablets: 21 active tablets, then 7 inert tablets.
Label update: January 4, 2022
View the Reclipsen referenceUS formulation reference
This US reference groups selected brands whose labels list desogestrel and ethinyl estradiol. It makes the label sequence visible but does not establish that products can be substituted.
Each card below links to a US DailyMed label. The grouping reflects the ingredient or pack family named in that label, not a clinical recommendation or substitution decision.
Ingredients: Desogestrel 0.15 mg and ethinyl estradiol 0.03 mg
Pack: 28 tablets: 21 active tablets, then 7 inert tablets.
Label update: January 4, 2022
View the Reclipsen referenceIngredients: Desogestrel 0.15 mg and ethinyl estradiol 0.02 mg, with ethinyl estradiol 0.01 mg tablets
Pack: 28 tablets: 21 active combination tablets, 2 inert tablets, then 5 ethinyl estradiol tablets.
Label update: March 26, 2024
View the Kariva referenceA shared ingredient family does not settle a pharmacy substitution or personal treatment decision. Check the exact name, strength, tablet sequence, and leaflet for the pack in your hand. Ask the dispensing pharmacist to explain any change.
Read the US pharmacy brand-switch guideNo. Ask a pharmacist about a substitution or equivalence question for your exact pack.
Open the official label linked above and read the leaflet supplied with your medicine.
Keep your routine together
Estroclic is a personal tracking app. It can help you organize information, but your patient leaflet, pharmacist, or clinician remains the right source for personal medical guidance.
Estroclic provides general information and personal tracking tools, not medical, pharmaceutical, or clinical advice. Check the patient information leaflet for your exact medicine and speak with a pharmacist or qualified healthcare professional when you need individual guidance.